ArticleVaccine2019

Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components.

Sofiya Fedosyuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.